Emcure Pharma is set to launch an Initial Public Offering (IPO) valued at Rs 1,952.03 crores. This IPO comprises a fresh issue of 0.79 crore shares, aggregating to Rs 800.00 crores, and an offer for sale of 1.14 crore shares, aggregating to Rs 1,152.03 crores. The subscription period for the Emcure Pharma IPO will open on July 3, 2024, and close on July 5, 2024. The allotment is expected to be finalized by Monday, July 8, 2024, with the shares scheduled to list on the BSE and NSE on Wednesday, July 10, 2024.
The price band for the Emcure Pharma IPO is set between ₹960 and ₹1008 per share. Retail investors can participate with a minimum lot size of 14 shares, requiring an investment of ₹14,112. For sNII (small Non-Institutional Investors), the minimum investment is 15 lots, totaling 210 shares and amounting to ₹211,680. For bNII (big Non-Institutional Investors), the minimum investment is 71 lots, totaling 994 shares and amounting to ₹1,001,952.
Emcure Pharma operates in the pharmaceutical sector, specializing in the development and manufacturing of a wide range of pharmaceutical products. The book running lead managers for this IPO are Kotak Mahindra Capital Company Limited, Axis Capital Limited, J.P. Morgan India Private Limited, and Jefferies India Private Limited, while Link Intime India Private Ltd will serve as the registrar for the issue.
Emcure Pharma IPO Details:
| Company Name | Emcure Pharmaceuticals Limited |
| Sector | Pharmaceuticals |
| IPO Type | Mainboard |
| IPO Open date | 03rd July 2024 |
| IPO Close date | 05th July 2024 |
| OFS | |
| Listing Exchanges | NSE, BSE |
| Share Holding Pre-issue | |
| DRHP Draft Prospectus | Click to check |
| RHP Draft Prospects | Click to check |
Emcure Pharma IPO Lot Size:
| Application | Lot Size | Shares | Amount |
| Retail (Min) | 1 | 14 | 14,112 |
| sHNI (Min) | 15 | 210 | 2,11,680 |
| bHNI (Min) | 71 | 994 | 10,01,952 |
Emcure Pharma IPO Timeline:
| IPO Open Date | 03rd July 2024 |
| IPO Close Date | 05th July 2024 |
| Basis of Allotment | 08th July 2024 |
| Refund Initiation Date | 09th July 2024 |
| Shares Credit to Demat | 09th July 2024 |
| Listing Date | 10th July 2024 |
FAQ
What is Grey Market Premium (GMP)?
The Grey Market Premium (GMP) represents the price at which an Initial Public Offering (IPO) is traded in the unregulated grey market before its official listing. It serves as an indicator of how the IPO might perform on the listing day. Seeing the latest GMP, investors can estimate the listing performance of the IPO.
